Automated Grain Yield Behavior Classification

A method for classifying grain stress evolution behaviors using unsupervised learning techniques is presented. The method is applied to analyze grain stress histories measured in-situ using high-energy X-ray diffraction microscopy (HEDM) from the aluminum-lithium alloy Al-Li 2099 at the elastic-plastic transition (yield). The unsupervised learning process automatically classified the grain stress histories into four groups: major softening, no work-hardening or softening, moderate work-hardening, and major work-hardening. The orientation and spatial dependence of these four groups are discussed. In addition, the generality of the classification process to other samples is explored

Mood and the Market: Can Press Reports of Investors’ Mood Predict Stock Prices?

We examined whether press reports on the collective mood of investors can predict changes in stock prices. We collected data on the use of emotion words in newspaper reports on traders’ affect, coded these emotion words according to their location on an affective circumplex in terms of pleasantness and activation level, and created indices of collective mood for each trading day. Then, by using time series analyses, we examined whether these mood indices, depicting investors’ emotion on a given trading day, could predict the next day’s opening price of the stock market. The strongest findings showed that activated pleasant mood predicted increases in NASDAQ prices, while activated unpleasant mood predicted decreases in NASDAQ prices. We conclude that both valence and activation levels of collective mood are important in predicting trend continuation in stock prices

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

The influence of hydrogen on the evolving microstructure during fatigue crack growth in metastable and stable austenitic stainless steels

The effect of high levels of internal hydrogen on the microstructure evolving during stage II fatigue crack growth was investigated through a series of tensile and fatigue studies in metastable (304) and stable (316, 316L) stainless steels. The first, a tensile study in 304 stainless steel, identified the underlying microstructure which resulted in the flat and quasi-cleavage features on the fracture surface of a hydrogen-charged tensile bar. The second study utilized single-edge notched tensile specimens loaded in fatigue, and compared the evolving microstructure ahead of a fatigue crack for cases of an uncharged, 10 wppm hydrogen-charged, and 104 wppm hydrogen-charged 304 and 316L alloy. The final fatigue study, a small fatigue crack growth study in round bars of 304 and 316, provided a contextual comparison of microstructures to previous results in literature. In the metastable 304 stainless steel, hydrogen is found to change the nature of the martensitic transformation and subsequent fracture path. This transformation is attributed to enhanced plasticity and hydrogen-dislocation interactions stabilizing the austenitic matrix and confining slip to particular close-packed planes. The martensite acts as a fast diffusion pathway for hydrogen, leading to final fracture along martensitic laths or cleavage planes. In 316L, the material deforms via slip and twinning and hydrogen does not induce a change in deformation mechanisms. Instead, the enhanced plasticity and hydrogen-dislocation interactions increase the degree of plasticity, leading to smaller dislocation cell sizes with thicker walls before the onset of twinning. The crack interacts with a heavily twinned structure superimposed on dislocation cells, resulting in a curvature of one twin-variant in the direction of crack growth and the formation of a refined region at the fracture surface. These structures are localized to the crack surface and limited in rotation in the presence of hydrogen. The presence of a hydrogen content above the solution-limit led to a strengthening effect over all other samples in the round bar samples for both 304 and 316. In the SENT studies, 304 stainless steel charged to these levels showed the greatest degree of hydrogen embrittlement, while in 316L stainless steel, the samples containing these levels of hydrogen were found to be stronger in fatigue life than the 10 wppm hydrogen-charged sample. Both of the 316L hydrogen-charged samples were weaker than their uncharged counterpart. Differences in the outcomes for the two studies was attributed to the geometry and testing condition employed. When strengthening was observed, the role of hydrogen was resolved to be two-fold: hydrogen hardens the matrix in the lattice, suppressing the process zone at the crack; and hydrogen at the dislocations enhances the plasticity experienced in the region where the material is yielding ahead of crack advance in the strain lobe. Irrespective of material class, increasing stress-state on the crack within the same stage of fatigue life leads to an increase in depth of the refinement layer and level of plasticity. The refinement at the surface can be attributed to the dislocation emission created during crack advance and the deformation induced in the crack wake. The former is the primary contributor to the SENT specimen studies, while the latter is responsible for the differences observed in the round-bar studies. In 316L, when the twin structure was observed to extend to the surface, regions of light and dark contrast were observed between the twinning bundle variants which corresponded to the peaks and troughs of the striations. This observation is counter to the current understanding that striations form during the crack advance process, independently of the evolved microstructure. The resulting microstructures in all hydrogen-induced studies are discussed in terms of the impact of hydrogen-dislocation interactions and enhanced plasticity. The evolving microstructure and unique observation of striations conforming to the microstructure developed ahead of crack advance emphasize the need to revisit how fatigue models are approached. Although a challenge, models must be informed by plasticity based arguments incorporating the deformation mechanisms observed in experiments to accurately reflect fatigue crack growth

Patients with Crohn's disease have longer post-operative in-hospital stay than patients with colon cancer but no difference in complications' rate

BACKGROUNDRight hemicolectomy or ileocecal resection are used to treat benign conditions like Crohn's disease (CD) and malignant ones like colon cancer (CC).AIMTo investigate differences in pre- and peri-operative factors and their impact on post-operative outcome in patients with CC and CD.METHODSThis is a sub-group analysis of the European Society of Coloproctology's prospective, multi-centre snapshot audit. Adult patients with CC and CD undergoing right hemicolectomy or ileocecal resection were included. Primary outcome measure was 30-d post-operative complications. Secondary outcome measures were post-operative length of stay (LOS) at and readmission.RESULTSThree hundred and seventy-five patients with CD and 2,515 patients with CC were included. Patients with CD were younger (median = 37 years for CD and 71 years for CC (P < 0.01), had lower American Society of Anesthesiology score (ASA) grade (P < 0.01) and less comorbidity (P < 0.01), but were more likely to be current smokers (P < 0.01). Patients with CD were more frequently operated on by colorectal surgeons (P < 0.01) and frequently underwent ileocecal resection (P < 0.01) with higher rate of de-functioning/primary stoma construction (P < 0.01). Thirty-day post-operative mortality occurred exclusively in the CC group (66/2515, 2.3%). In multivariate analyses, the risk of post-operative complications was similar in the two groups (OR 0.80, 95%CI: 0.54-1.17; P = 0.25). Patients with CD had a significantly longer LOS (Geometric mean 0.87, 95%CI: 0.79-0.95; P < 0.01). There was no difference in re-admission rates. The audit did not collect data on post-operative enhanced recovery protocols that are implemented in the different participating centers.CONCLUSIONPatients with CD were younger, with lower ASA grade, less comorbidity, operated on by experienced surgeons and underwent less radical resection but had a longer LOS than patients with CC although complication's rate was not different between the two groups

A modular IgG-scFv bispecific antibody topology

Here we present a bispecific antibody (bsAb) format in which a disulfide-stabilized scFv is fused to the C-terminus of the light chain of an IgG to create an IgG-scFv bifunctional antibody. When expressed in mammalian cells and purified by one-step protein A chromatography, the bsAb retains parental affinities of each binding domain, exhibits IgG-like stability and demonstrates in vivo IgG-like tumor targeting and blood clearance. The extension of the C-terminus of the light chain of an IgG with an scFv or even a smaller peptide does appear to disrupt disulfide bond formation between the light and heavy chains; however, this does not appear to affect binding, stability or in vivo properties of the IgG. Thus, we demonstrate here that the light chain of an IgG can be extended with an scFv without affecting IgG function and stability. This format serves as a standardized platform for the construction of functional bsAbs